Stem cell transplantation may hold the promise to treating many diseases before birth such as sickle cell anemia and muscular dystrophy. But first, researchers need to overcome many barriers, including rejection of stem cell transplants by the fetus. MacKenzie’s lab recently discovered that mothers’ T cells are responsible for rejecting the grafts and that this rejection may be avoided by using stem cells from the mother.

Tina Brock, who recently became associate dean of teaching and learning in the UCSF School of Pharmacy, offers her perspective on the science of education, the importance of interprofessional learning and teaching future pharmacists.